Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

• Schneider, L. S. Departments of Psychiatry and the Behavioral Sciences, and Neurology; Keck School of Medicine; Leonard Davis School of Gerontology of the University of Southern California; Los Angeles CA USA
• Mangialasche, F. Section of Gerontology and Geriatrics; University of Perugia; Perugia Italy
• Andreasen, N. Alzheimer Disease Research Center; Department of Neurobiology, Care Sciences and Society; Karolinska Institutet; Stockholm Sweden
• Feldman, H. Division of Neurology; University of British Columbia; Vancouver Canada
• Giacobini, E. Department of Internal Medicine, Rehabilitation, and Geriatrics; University of Geneva, Medical School; University Hospitals of Geneva; Thonex-Geneva Switzerland
• Jones, R. The Research Institute for the Care of Older People (RICE); University of Bath; Bath UK
• Mantua, V. European Assessment Office; Italian Medicines Agency (AIFA); Rome Italy
• Mecocci, P. Section of Gerontology and Geriatrics; University of Perugia; Perugia Italy
• Pani, L. European Assessment Office; Italian Medicines Agency (AIFA); Rome Italy
• Winblad, B. Alzheimer Disease Research Center; Department of Neurobiology, Care Sciences and Society; Karolinska Institutet; Stockholm Sweden
• Kivipelto, M. Department of Neurology; University of Eastern Finland; Kuopio Finland

Internal Medicine